%0 Journal Article
%T Criteria for determining the need for surgical treatment of tricuspid regurgitation during mitral valve replacement
%A Jigang He
%A Zhenya Shen
%A Yunsheng Yu
%A Haoyue Huang
%A Wenxue Ye
%A Yinglong Ding
%A Shaolei Yang
%J Journal of Cardiothoracic Surgery
%D 2012
%I BioMed Central
%R 10.1186/1749-8090-7-27
%X We reviewed the records of patients who underwent mitral valve replacement with or without (control) TR repair (DeVega or Kay procedure) from January 2005 to December 2008. Preoperative and 2-year postoperative echocardiographic measurements included right ventricular and atrial diameter, interventricular septum size, TR severity, ejection fraction, and pulmonary artery pressure.A total of 89 patients were included (control, n = 50; DeVega, n = 27; Kay, n = 12). Demographic and clinical characteristics were similar between groups. Cardiac variables were similar between the DeVega and Kay groups. Right atrium and ventricular diameter and ejection fraction were significantly decreased postoperatively both in the control and operation (DeVega + Kay) group (P < 0.05). Pulmonary artery pressure was significantly decreased postoperatively in-operation groups (P < 0.05). Our findings indicate that surgical intervention for TR should be considered during mitral valve replacement if any of the following preoperative criteria are met: right atrial transverse diameter > 57 mm; right ventricular end-diastolic diameter > 55 mm; pulmonary artery pressure > 58 mmHg.Our findings suggest echocardiography may be used as a rapid and simple means of determining which patients require TR repair during mitral valve replacement.Approximately 30% of patients with mitral stenosis have at least moderate tricuspid regurgitation (TR) [1,2]. Further, findings from several studies have demonstrated that 23% to 37% of patients develop serious TR after mitral valve replacement for rheumatic heart disease [3,4]. Matsuyama et al. [5] have also reported that 37% of patients who had Grade II TR before surgery developed > moderate TR after mitral valve replacement. This percentage is even higher for patients who receive surgical intervention for ischemic mitral valve disease, with up to 74% developing moderate to severe TR within 2 years of surgery [6,7]. The high prevalence of TR after mitral valve re
%K Surgical intervention
%K Mitral valve disease
%K Tricuspid valve regurgitation
%K Criteria
%U http://www.cardiothoracicsurgery.org/content/7/1/27